Genesis Drug Discovery & Development (GD³)
Anthony Rohr currently serves as the Director of Business Development at Genesis Drug Discovery & Development (GD³) since February 2024. Previously, Rohr held the position of Chief Operating Officer at DSI - DS InPharmatics from June 2023 to February 2024 and at GD³ from September 2021 to June 2023. Rohr also served as Chief Executive Officer of PharmOptima™, a member of the Genesis Biotechnology Group, from July 2020 to June 2023, and as President and Owner of Knowledgeable and Focused Consulting, LLC, from November 2017 to June 2023. Additional roles include Business Development and Project Manager at PharmOptima™ from November 2018 to July 2020, and various laboratory operations positions at MPI Research from July 2003 to October 2017. Rohr began a career in research as a Research Technician 2 at Baylor College of Medicine and has experience in management as a Manager/bartender at Dyckman Saloon. Anthony Rohr earned a B.S. in Biomedical Sciences from Western Michigan University between 1998 and 2002.
This person is not in the org chart
This person is not in any teams
Genesis Drug Discovery & Development (GD³)
Genesis Drug Discovery and Development (GD3), a member of the Genesis Biotechnology Group is a contract research organization focused on providing services to support preclinical drug development programs from discovery to candidate selection. Our diversified portfolio of services covers all the areas of preclinical drug discovery/development including Discovery Biology, Chemistry, DMPK/in-vivo pharmacology and Toxicology. The portfolio spans a wide range of therapeutic areas include oncology, ocular, inflammation, metabolic diseases, and microbiome.